JP2009535328A5 - - Google Patents

Download PDF

Info

Publication number
JP2009535328A5
JP2009535328A5 JP2009507631A JP2009507631A JP2009535328A5 JP 2009535328 A5 JP2009535328 A5 JP 2009535328A5 JP 2009507631 A JP2009507631 A JP 2009507631A JP 2009507631 A JP2009507631 A JP 2009507631A JP 2009535328 A5 JP2009535328 A5 JP 2009535328A5
Authority
JP
Japan
Prior art keywords
use according
caused
seq
syndrome
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009507631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535328A (ja
JP5323682B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2007/000413 external-priority patent/WO2007126363A2/en
Publication of JP2009535328A publication Critical patent/JP2009535328A/ja
Publication of JP2009535328A5 publication Critical patent/JP2009535328A5/ja
Application granted granted Critical
Publication of JP5323682B2 publication Critical patent/JP5323682B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009507631A 2006-04-27 2007-04-27 コンパートメント症候群の治療における使用のための抗分泌性タンパク質 Active JP5323682B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0600933 2006-04-27
SE0600933-6 2006-04-27
PCT/SE2007/000413 WO2007126363A2 (en) 2006-04-27 2007-04-27 Antisecretory protein for use in the treatment of compartment syndrome

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010245989A Division JP5285043B2 (ja) 2006-04-27 2010-11-02 コンパートメント症候群の治療における使用のための抗分泌性タンパク質

Publications (3)

Publication Number Publication Date
JP2009535328A JP2009535328A (ja) 2009-10-01
JP2009535328A5 true JP2009535328A5 (cg-RX-API-DMAC10.html) 2010-06-17
JP5323682B2 JP5323682B2 (ja) 2013-10-23

Family

ID=38655929

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009507631A Active JP5323682B2 (ja) 2006-04-27 2007-04-27 コンパートメント症候群の治療における使用のための抗分泌性タンパク質
JP2010245989A Active JP5285043B2 (ja) 2006-04-27 2010-11-02 コンパートメント症候群の治療における使用のための抗分泌性タンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010245989A Active JP5285043B2 (ja) 2006-04-27 2010-11-02 コンパートメント症候群の治療における使用のための抗分泌性タンパク質

Country Status (19)

Country Link
US (2) US8309513B2 (cg-RX-API-DMAC10.html)
EP (2) EP2363140B1 (cg-RX-API-DMAC10.html)
JP (2) JP5323682B2 (cg-RX-API-DMAC10.html)
KR (3) KR101757523B1 (cg-RX-API-DMAC10.html)
CN (3) CN101437533B (cg-RX-API-DMAC10.html)
AT (1) ATE526031T1 (cg-RX-API-DMAC10.html)
AU (1) AU2007244003B2 (cg-RX-API-DMAC10.html)
BR (2) BRPI0710858A2 (cg-RX-API-DMAC10.html)
CA (1) CA2650589C (cg-RX-API-DMAC10.html)
DK (3) DK2040734T3 (cg-RX-API-DMAC10.html)
ES (3) ES2472737T3 (cg-RX-API-DMAC10.html)
IL (1) IL194774A (cg-RX-API-DMAC10.html)
MX (1) MX2008013774A (cg-RX-API-DMAC10.html)
NZ (2) NZ572256A (cg-RX-API-DMAC10.html)
PL (2) PL2040734T3 (cg-RX-API-DMAC10.html)
RU (2) RU2457853C2 (cg-RX-API-DMAC10.html)
SG (1) SG171601A1 (cg-RX-API-DMAC10.html)
WO (1) WO2007126363A2 (cg-RX-API-DMAC10.html)
ZA (2) ZA200809114B (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101437533B (zh) 2006-04-27 2016-10-12 兰特门内阿斯-法克托尔公司 抗分泌蛋白对于治疗间室综合症的应用
EP2037950B1 (en) 2006-04-27 2014-04-23 Lantmännen AS-Faktor AB Further medical uses of antisecretory protein
EP2015767B1 (en) 2006-04-27 2016-01-06 Lantmännen AS-Faktor AB Use of antisecretory factor for treating intraocular hypertension
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
US8901083B2 (en) 2008-11-25 2014-12-02 Temple University Administration of angiocidin for the treatment of leukemia
JP5820277B2 (ja) * 2009-02-11 2015-11-24 ラントメネン・アーエス−ファクトール・アーベー 細胞取込を最適化するための抗分泌性因子(af)の使用
ES2887086T3 (es) * 2015-07-10 2021-12-21 Lantmaennen Functional Foods Ab Procedimiento para producir yema de huevo con alto contenido de af-16
CA3030316C (en) * 2016-07-18 2023-10-10 Lantmannen As-Faktor Ab Antisecretory factor 17
US20250177480A1 (en) * 2018-06-28 2025-06-05 Lantmännen Medical Ab Antisecretory Factor for Use in Treatment and/or Prevention of Acute Respiratory Failure
CN112770644A (zh) 2018-09-28 2021-05-07 兰特门内保健食品公司 包含麦芽化小麦的可消耗产品
EP3855934A2 (en) 2018-09-28 2021-08-04 Lantmännen Functional Foods AB A consumable product comprising malted dehulled oat
WO2021191431A1 (en) 2020-03-26 2021-09-30 Lantmännen Functional Foods Ab A consumable product comprising malted cereals for promoting recovery at physical activity

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) * 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
SE9604251L (sv) * 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
US7662169B2 (en) * 2000-09-05 2010-02-16 Wittmann Dietmar H Prosthesis and method for lowering abdominal pressure
GB0322645D0 (en) * 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
CN101437533B (zh) 2006-04-27 2016-10-12 兰特门内阿斯-法克托尔公司 抗分泌蛋白对于治疗间室综合症的应用
EP2037950B1 (en) 2006-04-27 2014-04-23 Lantmännen AS-Faktor AB Further medical uses of antisecretory protein
US8329650B2 (en) * 2007-10-19 2012-12-11 Trustees Of Boston University Method of treating ischemic injury with follistatin-like 1 polypeptide

Similar Documents

Publication Publication Date Title
JP2009535328A5 (cg-RX-API-DMAC10.html)
US7183381B2 (en) Composition of lactoferrin related peptides and uses thereof
ES2258841T3 (es) Procedimientos para reducir el colesterol con esporas de bacillus coagulans, sistemas y composiciones asociados.
JP5969457B2 (ja) 化合物およびそれらの使用
RU2008146734A (ru) Новый подход к лечению компартмент-синдрома
KR101734064B1 (ko) 마이시니딘 펩타이드로부터 유래한 신규 항균 펩타이드 및 이의 용도
EP3305305B1 (en) Silicate containing compositions and methods of treatment
KR20200130174A (ko) 미생물 유래 핵산 및 이의 용도
JPH11514990A (ja) 2−メルカプトエタノールアミン(2−mea)と類縁アミノチオール化合物および3,5−ジイソプロピルサリチル酸銅(▲ii▼)と類縁化合物の、各種疾患を予防および治療するための使用
US6486132B2 (en) Immunomodulator, immunomodulator food and immunomodulator feed
JPH07108857B2 (ja) 炎症過程及びアレルギー性疾患の予防及び治療のための細菌性製剤
US4384001A (en) Treatment of tumors with thiazolidine-4-carboxylic acid
JPS6320807B2 (cg-RX-API-DMAC10.html)
MX2014003256A (es) Uso de hidroxamatos de indolilo e indolinilo para tratar insuficiencia cardiaca o lesion neuronal.
JP2009509532A (ja) コンドロイチナーゼabci変異体を用いた組成物およびその使用方法
CN115778936B (zh) 松萝酸协同增效多黏菌素在抗革兰氏阴性细菌感染中的应用
CN117205188A (zh) 维生素k4在制备治疗黑色素瘤的药物中的应用
JP2002521002A (ja) 枯草菌の培養生菌に基づく生物薬剤、並びに細菌感染、ウイルス感染及び免疫不全症状の治療方法
CN1195542C (zh) 肝病保护剂
CA1285226C (en) Compositions containing a 2,4-diamino-pyrimidine and sulphadimidine
KR101971572B1 (ko) 신규한 살모넬라 엔테리티디스 특이 박테리오파지 및 이를 포함하는 항균 조성물
CN106798916A (zh) 一种治疗hpv感染的组合物及其应用
KR102608336B1 (ko) Pep27 펩타이드로부터 유래한 신규 펩타이드 및 이의 용도
KR102873912B1 (ko) 스트렙토코커스 파라우베리스 특이적 신규한 박테리오파지 jbf22001yu 및 이의 용도
EP0753309A2 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases